Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating the appropriateness of a community pharmacy model for a colorectal cancer screening program in Catalonia (Spain).
Santolaya M, Aldea M, Grau J, Estrada M, Barau M, Buron A, Francesc M, Castell A, Rodriguez C, Gascón P, Rius P, Guayta-Escolies R; PROCOLON research group (all members of this group are listed in Author Note). Santolaya M, et al. Among authors: aldea m. J Oncol Pharm Pract. 2017 Jan;23(1):26-32. doi: 10.1177/1078155215616278. Epub 2016 Jul 9. J Oncol Pharm Pract. 2017. PMID: 26563130
Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program.
Buron A, Román M, Augé JM, Macià F, Grau J, Sala M, Louro J, Martinez-Alonso M, Alvarez-Urturi C, Andreu M, Bessa X, Zaffalon D, Castells A, Pellisé M, Aldea M, Rivero L, Hernández C, Torá-Rocamora I, Castells X. Buron A, et al. Among authors: aldea m. Eur J Cancer. 2019 Jan;107:53-59. doi: 10.1016/j.ejca.2018.11.004. Epub 2018 Dec 10. Eur J Cancer. 2019. PMID: 30544059
Impact of a Primary Care intervention on the colorectal cancer early detection programme.
Luque Mellado FJ, Paino Pardal L, Condomines Feliu I, Tora-Rocamora I, Cuadras Rofastes M, Romero Díaz E, Pacheco Ortiz M, Camuñez Bravo JC, Aldea M, Grau Cano J; grupo de investigación PROCOLON. Luque Mellado FJ, et al. Among authors: aldea m. Gastroenterol Hepatol. 2019 Jun-Jul;42(6):351-361. doi: 10.1016/j.gastrohep.2019.01.007. Epub 2019 Apr 4. Gastroenterol Hepatol. 2019. PMID: 30954319 English, Spanish.
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.
Sepúlveda M, Aldea M, Escudero D, Llufriu S, Arrambide G, Otero-Romero S, Sastre-Garriga J, Romero-Pinel L, Martínez-Yélamos S, Sola-Valls N, Armangué T, Sotoca J, Escartín A, Robles-Cedeño R, Ramió-Torrentà L, Presas-Rodríguez S, Ramo-Tello C, Munteis E, Pelayo R, Gubieras L, Brieva L, Ortiz N, Hervás M, Mañé-Martínez MA, Cano A, Vela E, Tintoré M, Blanco Y, Montalban X, Graus F, Saiz A. Sepúlveda M, et al. Among authors: aldea m. Mult Scler. 2018 Dec;24(14):1843-1851. doi: 10.1177/1352458517735191. Epub 2017 Oct 6. Mult Scler. 2018. PMID: 28984163
Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS Unit.
Sepúlveda M, Llufriu S, Martínez-Hernández E, Català M, Artola M, Hernando A, Montejo C, Pulido-Valdeolivas I, Martínez-Heras E, Guasp M, Solana E, Llansó L, Escudero D, Aldea M, Prats C, Graus F, Blanco Y, Saiz A. Sepúlveda M, et al. Among authors: aldea m. Neurol Neuroimmunol Neuroinflamm. 2021 Jan 27;8(2):e954. doi: 10.1212/NXI.0000000000000954. Print 2021 Mar 4. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33504634 Free PMC article.
257 results